Site-directed Mutagenesis Reveals Regions Implicated in the Stability and Fiber Formation of Human λ3r Light Chains*

Background: λ6a and λ3r are the most implicated germ lines in light chain amyloidosis. Results: Mutagenesis at N-terminal, loop 40–60, and CDR3 regions affected λ3r fibrillogenesis. Conclusion: Changes at residues 7, 48, and 91 increased fibril formation while changes at residues 8 and 40 reverted fibrillogenesis. Significance: Characterization of light chain germ lines helps to identify key regions implicated in amyloidosis. Light chain amyloidosis (AL) is a disease that affects vital organs by the fibrillar aggregation of monoclonal light chains. λ3r germ line is significantly implicated in this disease. In this work, we contrasted the thermodynamic stability and aggregation propensity of 3mJL2 (nonamyloidogenic) and 3rJL2 (amyloidogenic) λ3 germ lines. Because of an inherent limitation (extremely low expression), Cys at position 34 of the 3r germ line was replaced by Tyr reaching a good expression yield. A second substitution (W91A) was introduced in 3r to obtain a better template to incorporate additional mutations. Although the single mutant (C34Y) was not fibrillogenic, the second mutation located at CDR3 (W91A) induced fibrillogenesis. We propose, for the first time, that CDR3 (position 91) affects the stability and fiber formation of human λ3r light chains. Using the double mutant (3rJL2/YA) as template, other variants were constructed to evaluate the importance of those substitutions into the stability and aggregation propensity of λ3 light chains. A change in position 7 (P7D) boosted 3rJL2/YA fibrillogenic properties. Modification of position 48 (I48M) partially reverted 3rJL2/YA fibril aggregation. Finally, changes at positions 8 (P8S) or 40 (P40S) completely reverted fibril formation. These results confirm the influential roles of N-terminal region (positions 7 and 8) and the loop 40–60 (positions 40 and 48) on AL. X-ray crystallography revealed that the three-dimensional topology of the single and double λ3r mutants was not significantly altered. This mutagenic approach helped to identify key regions implicated in λ3 AL.

[1]  Baltazar Becerril,et al.  A single mutation at the sheet switch region results in conformational changes favoring lambda6 light-chain fibrillogenesis. , 2010, Journal of molecular biology.

[2]  Randy J. Read,et al.  Acta Crystallographica Section D Biological , 2003 .

[3]  M. Ramirez-Alvarado,et al.  Structural alterations within native amyloidogenic immunoglobulin light chains. , 2009, Journal of molecular biology.

[4]  Charles Simon Bond,et al.  ALINE: a WYSIWYG protein-sequence alignment editor for publication-quality alignments. , 2009, Acta crystallographica. Section D, Biological crystallography.

[5]  A. Dispenzieri,et al.  Mutations in Specific Structural Regions of Immunoglobulin Light Chains Are Associated with Free Light Chain Levels in Patients with AL Amyloidosis , 2009, PloS one.

[6]  D. A. Fernández‐Velasco,et al.  Thermodynamic and kinetic characterization of a germ line human lambda6 light-chain protein: the relation between unfolding and fibrillogenesis. , 2009, Journal of molecular biology.

[7]  M. Ramirez-Alvarado,et al.  Structural Insights into the Role of Mutations in Amyloidogenesis* , 2008, Journal of Biological Chemistry.

[8]  D. A. Fernández‐Velasco,et al.  Influence of the germline sequence on the thermodynamic stability and fibrillogenicity of human lambda 6 light chains , 2008, Proteins.

[9]  B. Volkman,et al.  Altered Dimer Interface Decreases Stability in an Amyloidogenic Protein* , 2008, Journal of Biological Chemistry.

[10]  M. Ramirez-Alvarado,et al.  Biochemical and aggregation analysis of Bence Jones proteins from different light chain diseases , 2008, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[11]  K. Henrick,et al.  Inference of macromolecular assemblies from crystalline state. , 2007, Journal of molecular biology.

[12]  Randy J. Read,et al.  Phaser crystallographic software , 2007, Journal of applied crystallography.

[13]  Narayanaswamy Srinivasan,et al.  Nucleic Acids Research Advance Access published June 21, 2007 PIC: Protein Interactions Calculator , 2007 .

[14]  Min Zhu,et al.  Structural characterization of the partially folded intermediates of an immunoglobulin light chain leading to amyloid fibrillation and amorphous aggregation. , 2007, Biochemistry.

[15]  X. Daura,et al.  AGGRESCAN: a server for the prediction and evaluation of "hot spots" of aggregation in polypeptides , 2007, BMC Bioinformatics.

[16]  Flavio Seno,et al.  Insight into the Structure of Amyloid Fibrils from the Analysis of Globular Proteins , 2006, PLoS Comput. Biol..

[17]  G. Merlini,et al.  Dangerous small B-cell clones. , 2006, Blood.

[18]  H. Neumann,et al.  Primary (AL) amyloidosis in plasma cell disorders. , 2006, The oncologist.

[19]  C. Dobson,et al.  Protein misfolding, functional amyloid, and human disease. , 2006, Annual review of biochemistry.

[20]  P. Evans,et al.  Scaling and assessment of data quality. , 2006, Acta crystallographica. Section D, Biological crystallography.

[21]  G. Merlini,et al.  Clinical aspects of systemic amyloid diseases. , 2005, Biochimica et biophysica acta.

[22]  Kevin Cowtan,et al.  research papers Acta Crystallographica Section D Biological , 2005 .

[23]  L. Serrano,et al.  Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins , 2004, Nature Biotechnology.

[24]  P. Adams,et al.  Structural basis of light chain amyloidogenicity: comparison of the thermodynamic properties, fibrillogenic potential and tertiary structural features of four Vλ6 proteins , 2004, Journal of molecular recognition : JMR.

[25]  Mateusz Nowak,et al.  Immunoglobulin kappa light chain and its amyloidogenic mutants: A molecular dynamics study , 2004, Proteins.

[26]  J. Wall,et al.  Towards understanding the structure-function relationship of human amyloid disease. , 2004, Current drug targets.

[27]  R. Fonseca,et al.  Immunoglobulin light chain variable (V) region genes influence clinical presentation and outcome in light chain-associated amyloidosis (AL). , 2003, Blood.

[28]  E. Ascari,et al.  Analysis of Vλ-Jλ expression in plasma cells from primary (AL) amyloidosis and normal bone marrow identifies 3r(λIII) as a new amyloid-associated germline gene segment , 2002 .

[29]  James C. Sacchettini,et al.  Therapeutic strategies for human amyloid diseases , 2002, Nature Reviews Drug Discovery.

[30]  J. Richardson,et al.  Natural β-sheet proteins use negative design to avoid edge-to-edge aggregation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[31]  C. Martínez,et al.  The tropism of organ involvement in primary systemic amyloidosis: contributions of Ig V(L) germ line gene use and clonal plasma cell burden. , 2001, Blood.

[32]  C. Soto,et al.  Protein misfolding and disease; protein refolding and therapy , 2001, FEBS letters.

[33]  G. Merlini,et al.  Review: immunoglobulin light chain amyloidosis--the archetype of structural and pathogenic variability. , 2000, Journal of structural biology.

[34]  A G Leslie,et al.  Biological Crystallography Integration of Macromolecular Diffraction Data , 2022 .

[35]  M. Schell,et al.  Thermodynamic instability of human lambda 6 light chains: correlation with fibrillogenicity. , 1999, Biochemistry.

[36]  P. Saggau,et al.  Simultaneous optical recording of membrane potential and intracellular calcium from brain slices. , 1999, Methods.

[37]  P. Lipsky,et al.  Molecular Mechanisms and Selection Influence the Generation of the Human VλJλ Repertoire , 1999, The Journal of Immunology.

[38]  P. Lipsky,et al.  Molecular mechanisms and selection influence the generation of the human V lambda J lambda repertoire. , 1999, Journal of immunology.

[39]  C. Murphy,et al.  In vitro immunoglobulin light chain fibrillogenesis. , 1999, Methods in enzymology.

[40]  K. Olsen,et al.  Extended analysis of AL-amyloid protein from abdominal wall subcutaneous fat biopsy: kappa IV immunoglobulin light chain. , 1998, Biochemical and biophysical research communications.

[41]  Weiss,et al.  Differences in kappa to lambda (κ:λ) ratios of serum and urinary free light chains , 1998 .

[42]  D. Milardi,et al.  An alternative approach in the structure-based predictions of the thermodynamics of protein unfolding. , 1997, Biophysical chemistry.

[43]  G. Murshudov,et al.  Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.

[44]  M. Lefranc,et al.  Sequence and evolution of the human germline V lambda repertoire. , 1996, Journal of molecular biology.

[45]  M. Schiffer,et al.  Pitfalls of molecular replacement: the structure determination of an immunoglobulin light-chain dimer. , 1996, Acta crystallographica. Section D, Biological crystallography.

[46]  M. Schiffer,et al.  Recombinant immunoglobulin variable domains generated from synthetic genes provide a system for in vitro characterization of light‐chain amyloid proteins , 1994, Protein science : a publication of the Protein Society.

[47]  M. Schiffer,et al.  Structure and properties of human immunoglobulin light-chain dimers. , 1995, Methods in molecular biology.

[48]  M. Hurle,et al.  A role for destabilizing amino acid replacements in light-chain amyloidosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[49]  P. Lansbury,et al.  The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. , 1993, Biochemistry.

[50]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[51]  L. Pearl,et al.  Recursive PCR: a novel technique for total gene synthesis. , 1992, Protein engineering.

[52]  S. Yadav,et al.  MEASURING THE CONFORMATIONAL STABILITY OF PROTEINS , 1992 .

[53]  H R Hoogenboom,et al.  By-passing immunization. Human antibodies from V-gene libraries displayed on phage. , 1991, Journal of molecular biology.

[54]  M. Hosokawa,et al.  Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1. , 1989, Analytical biochemistry.

[55]  R. Poljak,et al.  Amino acid sequence of the variable region of the light (lambda) chain from human myeloma cryoimmunoglobulin IgG Hil. , 1978, Biochemistry.

[56]  G J Williams,et al.  The Protein Data Bank: a computer-based archival file for macromolecular structures. , 1978, Archives of biochemistry and biophysics.